atrial fibrillation, LARIAT

Doctors at the Stony Brook Heart Institute Electrophysiology Lab are using a new nonsurgical technique called the Lariat Suture Delivery Device to treat patients with atrial fibrillation who cannot tolerate blood-thinning medication.

ScImage Inc. has partnered with Cedaron Medical Inc. to deliver CardiacCare with ScImage’s enterprise picture archive and communications system (PACS), PICOM365. 

Boston Scientific Corp. received CE marking and launched in Europe the Ingevity family of magnetic resonance imaging (MRI) compatible pacing leads. The Ingevity family is a set of leads that can be placed using a 6 French introducer, including passive and active fixation models. Ingevity MRI pacing leads are part of the ImageReady MR-conditional pacemaker system, which includes Vitalio MRI, Formio MRI, Advantio MRI and Ingenio MRI pulse generators. When used with the Latitude NXT patient management system, these devices wirelessly monitor patients for conditions such as atrial arrhythmias.

AccessClosure plans to launch the Mynx Ace Vascular Closure Device at the 2014 American College of Cardiology meeting, March 29-31. It is an upgrade of the company’s Mynx mechanical vascular closure product. It is designed to provide patient comfort and uses an easy-to-use deployment system to seal femoral artery access sites. The device helps reduce time to hemostasis and ambulation in patients who have undergone diagnostic or interventional endovascular procedures.

Today, PinnacleHealth is home to one of the foremost transcatheter aortic valve replacement (TAVR) programs in the world. But in the program’s infancy, PinnacleHealth needed to develop relationships between clinicians and facilitate their collaboration using the right diagnostic imaging technology to ensure success. Using a multidisciplinary, collaborative commitment from clinicians and a state-of-the-art hybrid OR lab anchored by Toshiba’s Infinix-i cardiovascular imaging system, PinnacleHealth is improving outcomes for some of its sickest patients. As one of the finest TAVR programs available today, it is also achieving fewer readmissions and lowering costs.

Surgeons in France have successfully replaced the aortic valve in two patients without opening the chest during surgery. The procedure, using totally endoscopic aortic valve replacement (TEAVR), shows potential for improving quality of life of heart patients by offering significantly reduced chest trauma. It is described in The Journal of Thoracic and Cardiovascular Surgery.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now